SINCO PHARMA(06833),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

06833 SINCO PHARMA

Closed 04-08 14:19:18

0.182

-0.003

-1.62%

High0.182	Low0.182	Vol92.00K
Open0.182	D1 Closing0.185	Amplitude0.00%
Mkt Cap370.01M	Tradable Cap369.99M	Total Shares2.03B
T/O16.82K	T/O Rate0.00%	Tradable Shares2.03B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"06833","market":"HK","secType":"STK","nameCN":"SINCO PHARMA","latestPrice":0.182,"timestamp":1775629158204,"preClose":0.185,"halted":0,"volume":92000,"delay":0,"changeRate":-0.01621621621621623,"floatShares":2032890585,"shares":2032999999,"eps":0.019507467713008,"marketStatus":"Closed","change":-0.003,"latestTime":"04-08 14:19:18","open":0.182,"high":0.182,"low":0.182,"amount":16824,"amplitude":0,"askPrice":0.183,"askSize":12000,"bidPrice":0.182,"bidSize":12000,"shortable":0,"etf":0,"ttmEps":0.019507467713008,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775698200000},"marketStatusCode":5,"adr":0,"listingDate":1457539200000,"exchange":"SEHK","adjPreClose":0.185,"dividendRate":0.010989,"openAndCloseTimeList":[[1775611800000,1775620800000],[1775624400000,1775635200000]],"volumeRatio":0.833333,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06833","defaultTab":"news","newsList":[{"id":"1157928665","title":"SINCO PHARMA (06833) Announces Annual Results: Profit Attributable to Owners Declines 16.9% to RMB 34.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1157928665","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157928665?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:50","pubTimestamp":1774533017,"startTime":"0","endTime":"0","summary":"SINCO PHARMA (06833) has released its annual financial results for the period ending December 31, 2025. The Group reported revenue of RMB 2.085 billion, representing a decrease of 26.1% compared to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142511745","title":"Sinco Pharma 2025 Results: Revenue Slides 26%, Net Profit Down 16.9% Amid Lower Albumin Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1142511745","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142511745?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:44","pubTimestamp":1774532685,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (Sinco Pharma) reported full-year 2025 revenue of RMB 2.08 billion, a year-on-year decline of 26.10% or RMB 736.70 million, driven mainly by a reduction of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187480454","title":"Sinco Pharma Declares HK$0.167 Final Dividend for FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1187480454","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187480454?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:44","pubTimestamp":1774532663,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited announced on 26 March 2026 a final ordinary dividend of HK$0.167 per share for the financial year ended 31 December 2025, subject to shareholder approval at the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622863753","title":"Sinco Pharmaceuticals FY2025 net profit drops 16.9% to RMB34.9 million; revenue falls 26.1% to RMB2.1 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2622863753","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622863753?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:38","pubTimestamp":1774532296,"startTime":"0","endTime":"0","summary":"Sinco published an annual results announcement reporting revenue of RMB2.08 billion, down 26.1%, mainly due to lower sales volume of human albumin solution.Gross profit fell 25.9% to RMB222.09 million, while gross margin was 10.7%, up 0.1 percentage point.Profit attributable to owners declined 16.9% to RMB34.85 million, and basic and diluted EPS was RMB0.017.Finance costs rose to RMB33.94 million, driven mainly by a RMB12.99 million guarantee fee paid to chairman Huang and higher interest and letter-of-credit charges.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL85fN1s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622486375","title":"Sinco Pharmaceuticals FY2025 final dividend is proposed at HKD 0.167 per share; payment date is set for June 4, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622486375","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622486375?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:38","pubTimestamp":1774532291,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals proposed a final ordinary dividend of HKD 0.17 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL66xGmW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123263759","title":"Sinco Pharma (06833) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1123263759","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123263759?lang=en_us&edition=fundamental","pubTime":"2026-03-16 16:41","pubTimestamp":1773650468,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (Sinco Pharma, 06833) has scheduled a board meeting for Thursday, 26 March 2026 in Sichuan, PRC. The agenda includes: 1. Reviewing and approving the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619453987","title":"Sinco Pharmaceuticals schedules board meeting to approve annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2619453987","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619453987?lang=en_us&edition=fundamental","pubTime":"2026-03-16 16:34","pubTimestamp":1773650062,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals will hold a board meeting on 26 March 2026 to consider and approve the group’s annual results for the year ended 31 December 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL3q6qw8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193824649","title":"Sinco Pharmaceuticals (06833) Maintains 2.03 Billion Issued Shares in February 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1193824649","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193824649?lang=en_us&edition=fundamental","pubTime":"2026-03-02 16:47","pubTimestamp":1772441242,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (06833) submitted its monthly return for the period ended 28 February 2026. The authorized share capital remained at 10,000,000,000 ordinary shares, each with a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139291131","title":"Sinco Pharmaceuticals (06833) Publishes January 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1139291131","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139291131?lang=en_us&edition=fundamental","pubTime":"2026-02-02 20:03","pubTimestamp":1770033837,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (stock code: 06833) published its Monthly Return for the period ended 31 January 2026, confirming that its authorized share capital remained at 10,000,000,000...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603627877","title":"Investors Don't See Light At End Of Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Tunnel","url":"https://stock-news.laohu8.com/highlight/detail?id=2603627877","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603627877?lang=en_us&edition=fundamental","pubTime":"2026-01-15 08:54","pubTimestamp":1768438473,"startTime":"0","endTime":"0","summary":"With a price-to-earnings (or \"P/E\") ratio of 6.8x Sinco Pharmaceuticals Holdings Limited ( HKG:6833 ) may be sending...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6833/sinco-pharmaceuticals-holdings-shares/news/investors-dont-see-light-at-end-of-sinco-pharmaceuticals-hol","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6833/sinco-pharmaceuticals-holdings-shares/news/investors-dont-see-light-at-end-of-sinco-pharmaceuticals-hol","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1197","06833","BK4211","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589386432","title":"Sinco Pharma Says Internal-Control Gaps Remedied After Review; Shares Slip 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589386432","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589386432?lang=en_us&edition=fundamental","pubTime":"2025-12-08 12:45","pubTimestamp":1765169102,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals  said it has completed remediation measures addressing deficiencies identified in an internal control review tied to a 2021 interest-free loan, according to a Dec. 05 Hong Kong bourse filing.Shares of the firm were down over 4% in Monday's midday trade.The company implemented revised connected-transaction procedures, strengthened fund management and payment approval policies, introduced petty cash controls, updated contract management steps, and formalised bank-account handling requirements.A follow-up review submitted concluded that the measures adequately address the previously identified gaps, according to the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170000324","title":"Sinco Pharmaceuticals (06833) Announces Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1170000324","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170000324?lang=en_us&edition=fundamental","pubTime":"2025-12-01 16:46","pubTimestamp":1764578795,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (06833) released its monthly return, confirming no changes in its authorized share capital and issued shares for November 2025. The authorized share capital...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinco-pharm.com","stockEarnings":[{"period":"1week","weight":0.0393},{"period":"1month","weight":0.0882},{"period":"3month","weight":0.0452},{"period":"6month","weight":-0.0464},{"period":"1year","weight":0.0109},{"period":"ytd","weight":0.0452}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sinco Pharmaceuticals Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive marketing, promotion and channel management service for imported pharmaceutical products and medical devices. The Company operates three segments. The Sale of Imported Pharmaceutical Products segment engages in marketing, promotion, channel management activities for the sale of improved human plasma-based pharmaceuticals, antibiotics and other pharmaceuticals focused on therapeutic areas and complementary to human plasma-based products and other categories. The Research and Manufacturing of Aesthetic Medicine segment engages in the research and development and manufacturing of aesthetic medicine. The Medical Beauty Services segment engages in the provision of medical beauty services through its subsidiary company. The Company conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.039713},{"month":2,"riseRate":0.5,"avgChangeRate":0.108153},{"month":3,"riseRate":0.5,"avgChangeRate":0.034834},{"month":4,"riseRate":0.090909,"avgChangeRate":-0.081276},{"month":5,"riseRate":0.3,"avgChangeRate":-0.048869},{"month":6,"riseRate":0.2,"avgChangeRate":-0.079997},{"month":7,"riseRate":0.5,"avgChangeRate":0.07039},{"month":8,"riseRate":0.2,"avgChangeRate":-0.173894},{"month":9,"riseRate":0.4,"avgChangeRate":-0.015219},{"month":10,"riseRate":0.6,"avgChangeRate":0.146368},{"month":11,"riseRate":0.4,"avgChangeRate":0.058607},{"month":12,"riseRate":0.7,"avgChangeRate":0.063452}],"exchange":"SEHK","name":"SINCO PHARMA","nameEN":"SINCO PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SINCO PHARMA(06833),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SINCO PHARMA(06833) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SINCO PHARMA,06833,SINCO PHARMA股票,SINCO PHARMA股票老虎,SINCO PHARMA股票老虎国际,SINCO PHARMA行情,SINCO PHARMA股票行情,SINCO PHARMA股价,SINCO PHARMA股市,SINCO PHARMA股票价格,SINCO PHARMA股票交易,SINCO PHARMA股票购买,SINCO PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SINCO PHARMA(06833),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SINCO PHARMA(06833) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}